The US International Development Finance Corporation (DFC) has signed a letter of interest to provide a $765 million loan to Eastman Kodak to support the launch of Kodak Pharmaceuticals at a ceremony at the company’s main site in Rochester, New York state.
Lonza has reported 7.7% growth in sales in constant currency terms during 1H 2020 to CHF 3,074 million, with a core EBITDA margin of 29.1%. This, as in 2019, was largely driven by the Lonza Pharma Biotech & Nutrition (LBPN) segment, which had 10.8%3 sales growth and a margin of 34.1%.
Lanxess has announced that it is focusing its water treatment technologies business on the ion exchange (IX) resins business and will build a new plant. As a result, it is selling its reverse osmosis (RO) membranes business to Suez of France, on undisclosed terms.
Azelis has extended its reach into Israel by acquiring Orkila Israel, a speciality chemicals distributor in Israel active in multiple market segments, including agrochemicals, animal nutrition, personal care, food, pharmaceuticals and industrial chemicals. Terms were not disclosed.
Ahead of the European Council meeting on 17 July, CEFIC called on EU member states “to urgently agree an EU Recovery Plan to restart Europe’s economy and kick off investments towards a green and digital transition”.